News - Tranzyme

Filter

Current filters:

Tranzyme

Popular Filters

Tranzyme exploring options, including sale of the firm; is Ache up for sale?

11-02-2013

Following two recent R&D pipeline disappointments, the board of directors of US biotech firm Tranzyme…

Ache Laboratorios FarmaceuticosBiotechnologyMergers & AcquisitionsNorth AmericaPharmaceuticalSouth AmericaTranzyme

Tranzyme and Norgine's ulimorelin fails to meet endpoints

27-05-2012

USA-based Tranzyme Pharma (Nasdaq: TZYN) and independent Dutch drugmaker Norgine have announced disappointing…

Gastro-intestinalsNorginePharmaceuticalResearchTranzymeTZP-102ulimorelin

Tranzyme and Norgine bowel cancer drug fails in Ph III

12-03-2012

USA-based Tranzyme Pharma (Nasdaq: TZYM) and independent drugmaker Norgine of the Netherlands yesterday…

NorgineOncologyPharmaceuticalResearchTranzymeulimorelin

Tranzyme Pharma extends drug discovery collaboration with Bristol-Myers Squibb

09-11-2011

USA-based Tranzyme Pharma (Nasdaq: TZYM) says it has extended its chemistry-based drug discovery collaboration…

Bristol-Myers SquibbLicensingPharmaceuticalResearchTranzyme

Back to top